Recombinant multi-species B3GALT2 protein for cell curture, in vitro study, in vivo study, benchmark, drug discovery & MOA research and positive control for the diagnosis
Genemedi produces recombinant Human, Cynomolgus/ Rhesus macaque, Rat, Mouse, Feline, Canine, Bovine, Equine B3GALT2 protein for cell curture, in vitro study, in vivo study, benchmark, drug discovery & MOA research and positive control for the diagnosis.
This gene is a member of the beta-1,3-galactosyltransferase (beta3GalT) gene family. This family encodes type II membrane-bound glycoproteins with diverse enzymatic functions using different donor substrates (UDP-galactose and UDP-N-acetylglucosamine) and different acceptor sugars (N-acetylglucosamine, galactose, N-acetylgalactosamine). The beta3GalT genes are distantly related to the Drosophila Brainiac gene and have the protein coding sequence contained in a single exon. The beta3GalT proteins also contain conserved sequences not found in the beta4GalT or alpha3GalT proteins. The carbohydrate chains synthesized by these enzymes are designated as type 1, whereas beta4GalT enzymes synthesize type 2 carbohydrate chains. The ratio of type 1:type 2 chains changes during embryogenesis. By sequence similarity, the beta3GalT genes fall into at least two groups: beta3GalT4 and 4 other beta3GalT genes (beta3GalT1-3, beta3GalT5). This gene encodes a protein that functions in N-linked glycoprotein glycosylation and shows strict donor substrate specificity for UDP-galactose. [provided by RefSeq, Jul 2008]
The Alternative Names of target: 3-GalTase 2,3-galactosyltransferase 2,B3GALT2,B3galt2,BETA3GALT2,Beta-1,Beta3Gal-T2,Beta3GalT2,GLCT2,UDP-galactose:2-acetamido-2-deoxy-D-glucose 3beta-galactosyltransferase 2,beta3Gal-T2
Go
to B3GALT2 products collection
>>
(antibodies,
antigen, VLP, mRNA, ORF viral vector, etc)
Product information
| Catalog No. | Product Name | Species Reactivity |
|---|---|---|
| GM-Tg-hg-IP0403-Ag-1/ GM-Tg-hg-IP0403-Ag-2 | Human B3GALT2 protein | Human |
| GM-Tg-rg-IP0403-Ag-1/ GM-Tg-rg-IP0403-Ag-2 | Rat B3GALT2 protein | Rat |
| GM-Tg-mg-IP0403-Ag-1/ GM-Tg-mg-IP0403-Ag-2 | Mouse B3GALT2 protein | Mouse |
| GM-Tg-cynog-IP0403-Ag-1/ GM-Tg-cynog-IP0403-Ag-2 | Cynomolgus/Rhesus macaque B3GALT2 protein | Cynomolgus/ Rhesus macaque |
| GM-Tg-felg-IP0403-Ag-1/ GM-Tg-felg-IP0403-Ag-2 | Feline B3GALT2 protein | Feline |
| GM-Tg-cang-IP0403-Ag-1/ GM-Tg-cang-IP0403-Ag-2 | Canine B3GALT2 protein | Canine |
| GM-Tg-bovg-IP0403-Ag-1/ GM-Tg-bovg-IP0403-Ag-2 | Bovine B3GALT2 protein | Bovine |
| GM-Tg-equg-IP0403-Ag-1/ GM-Tg-equg-IP0403-Ag-2 | Equine B3GALT2 protein | Equine |
Size: 1mg | 10mg | 100mg
Product Description
| Catalog No. |
GM-Tg-hg-IP0403-Ag-1/ GM-Tg-hg-IP0403-Ag-2;
GM-Tg-rg-IP0403-Ag-1/ GM-Tg-rg-IP0403-Ag-2;
GM-Tg-mg-IP0403-Ag-1/ GM-Tg-mg-IP0403-Ag-2; GM-Tg-cynog-IP0403-Ag-1/ GM-Tg-cynog-IP0403-Ag-2; GM-Tg-felg-IP0403-Ag-1/ GM-Tg-felg-IP0403-Ag-2; GM-Tg-cang-IP0403-Ag-1/ GM-Tg-cang-IP0403-Ag-2; GM-Tg-bovg-IP0403-Ag-1/ GM-Tg-bovg-IP0403-Ag-2; GM-Tg-equg-IP0403-Ag-1/ GM-Tg-equg-IP0403-Ag-2 |
| Products Name | B3GALT2 protein |
| Species | Human, Cynomolgus/ Rhesus macaque, rat, mouse, Feline, Canine, Bovine, Equine |
| Target Name | B3GALT2 |
| Protein Sub-location | Introcelluar Protein |
| Isotypes | Recombinant protein |
| Expression platform | Mammalian cell |
| Bioactivity validation | Affintiy&bioactivity validated by ELISA, cell culture validated. |
| Tag | His |
| Products description | Recombinant Human, Cynomolgus/ Rhesus macaque, Rat, Mouse, Feline, Canine, Bovine, Equine B3GALT2 protein was expressed in mammalian cell expression system and is expressed with 6 HIS tag at the C-terminus for cell culture, ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic). |
| Purity | Purity: ≥95% (SDS-PAGE) |
| Application | In vitro study, in vivo study, benchmark, positive control for the diagnosis. Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research. |
| Formulation & Reconstitution |
Lyophilized from GM's Protein Stability Buffer2
(PSB2,Confidential Ingredients) or PBS
(pH7.4); For PSB2, reconstituted with 0.9% sodium chloride; For PBS, reconstituted with ddH2O. |
| Storage | Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles. |
Reference
About Gmab

GMab, developed by GeneMedi, constitutes an
advanced library of recombinant
monoclonal antibodies, each meticulously
designed to target specific molecular
entities. Leveraging the sophisticated
capabilities of GM’s Taurus™ and LIBRA™
platforms, GMab synthesizes antibodies
characterized by high binding affinity,
exceptional physicochemical stability, and
optimal developability profiles.
Through
expression in mammalian cell lines, GMab has
been established as a paradigmatic
reference antibody. It holds significance in
myriad domains of biological drug
discovery, encompassing cellular cultivation,
innovative assay methodologies,
strategic animal model systematization, in-depth
pharmacokinetic & pharmacodynamic
(PK/PD) modeling, and intricate mechanism of
action (MOA) investigations.